Hormonal Therapy

Pasadena, USA | May 1, 2026 Arrowhead Pharmaceuticals has received approval from Australia’s Therapeutic Goods Administration (TGA) for REDEMPLO®...

Pittsburgh, USA | May 1, 2026 Viatris has announced multiple clinical data presentations for its investigational low-dose estrogen combined...